Instituto de Investigación Sanitaria Biobizkaia-ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2022

  1. Desarrollo y validación de un modelo de estratificación del riesgo en pacientes con neumonía por SARS-CoV-2 (Covid Cruces)

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 119, Núm. 1, pp. 3-11

  2. Validación del modelo de predicción de mortalidad ISARIC 4C para SARS-CoV-2 en Hospital Universitario Cruces

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 119, Núm. 1, pp. 12-19

2021

  1. Baja transmisión del SARS-CoV-2 en el ámbito escolar: estudio poblacional en Euskadi

    Revista espanola de salud publica, Vol. 95

2020

  1. Inequalities in participation in colorectal cancer screening programmes: A systematic review

    European Journal of Public Health, Vol. 30, Núm. 3, pp. 416-425

  2. Transfusional optimization in liver transplant using viscoelastic test guided therapy

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 67, Núm. 6, pp. 292-300

2019

  1. Implementation of NeoKissEs in Spain: A validated surveillance system for nosocomial sepsis in very low birth weight infants

    Anales de Pediatria, Vol. 91, Núm. 1, pp. 3-12

  2. Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years

    European Journal of Gastroenterology and Hepatology, Vol. 31, Núm. 2, pp. 197-204

  3. Quality indicators and patient satisfaction in colonoscopy

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 2, pp. 73-81

2018

  1. Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model

    BMC Cancer, Vol. 18, Núm. 1

  2. Factors related to the participation and detection of lesions in colorectal cancer screening programme-based faecal immunochemical test

    European Journal of Public Health, Vol. 28, Núm. 6, pp. 1143-1148

  3. Screening colonoscopy and risk of adverse events among individuals undergoing fecal immunochemical testing in a population-based program: A nested case-control study

    United European Gastroenterology Journal, Vol. 6, Núm. 5, pp. 755-764

2017

  1. Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain)

    World Journal of Gastroenterology, Vol. 23, Núm. 15, pp. 2731-2742

  2. Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model

    BMC Public Health, Vol. 18, Núm. 1

  3. Population-based colorectal cancer screening programmes using a faecal immunochemical test: Should faecal haemoglobin cut-offs differ by age and sex?

    BMC Cancer, Vol. 17, Núm. 1

2016

  1. Considerations on urea cycle disorders: a child with ornithine transcarbamylase deficiency

    PEDIATRIC ANESTHESIA AND CRITICAL CARE JOURNAL, Vol. 4, Núm. 1, pp. 28-29